Allspring Global Investments
TXG icon

Allspring Global Investments’s 10x Genomics TXG Stock Holding History

Allspring Global Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$613K Buy
+15,690
New +$411K ﹤0.01% 1397
2025
Q2 		– Sell
-26,244
Closed -$228K – 1802
2025
Q1 		$228K Sell
26,244
-2,994
-10% -$37.7K ﹤0.01% 1639
2024
Q4 		$415K Sell
29,238
-9,725
-25% -$153K ﹤0.01% 1501
2024
Q3 		$880K Buy
38,963
+37,326
+2,280% +$772K ﹤0.01% 1358
2024
Q2 		$31.8K Buy
1,637
+939
+135% +$24.6K ﹤0.01% 2028
2024
Q1 		$26.2K Buy
698
+371
+113% +$16.3K ﹤0.01% 2050
2023
Q4 		$18.3K Sell
327
-3,202
-91% -$139K ﹤0.01% 1975
2023
Q3 		$146K Buy
+3,529
New +$184K ﹤0.01% 1851
2022
Q2 		– Sell
-724,149
Closed -$55.1M – 2935
2022
Q1 		$55.1M Sell
724,149
-25,419
-3% -$2.22M 0.07% 347
2021
Q4 		$112M Buy
+749,568
New +$115M 0.12% 216

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allspring Global Investments's TXG Position: Q2 2026 in Review

Allspring Global Investments opened a new position in 10x Genomics (TXG) in Q2 2026: 15,690 shares worth $613K. The stake represents ﹤0.01% of the portfolio and ranks #1397 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in TXG as recently as Q1 2025.

Allspring Global Investments first reported a position in TXG in Q4 2021 and has held it in 10 quarters since. The position peaked at $112M in Q4 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Allspring Global Investments held 15,690 shares of 10x Genomics worth $613K as of Q2 2026.
  • 10x Genomics was a new Allspring Global Investments position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1397 holding.
  • Allspring Global Investments first reported a position in 10x Genomics in Q4 2021 and has held it in 10 quarters since.
  • Allspring Global Investments's 10x Genomics position peaked at $112M in Q4 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.